Chlorpyrifos and its metabolites alter gene expression at non-cytotoxic concentrations in D3 mouse embryonic stem cells under in vitro differentiation: Considerations for embryotoxic risk assessment

被引:36
作者
Estevan, Carmen [1 ]
Vilanova, Eugenio [1 ]
Sogorb, Miguel A. [1 ]
机构
[1] Univ Miguel Hernandez Elche, Inst Bioingn, Elche 03202, Spain
关键词
Chlorpyrifos; Chlorpyrifos-oxon; Embryonic stem cell; Differentiation; Risk assessment; DEVELOPMENTAL NEUROTOXICITY; PC12; CELLS; EXPOSURE; CYTOTOXICITY; INSECTICIDES; VALIDATION;
D O I
10.1016/j.toxlet.2012.11.026
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The effects of organophosphate insecticide chlorpyrifos (CPF) on development are currently under discussion. CPF and its metabolites, chlorpyrifos-oxon (CPO) and 3,5,6-trichloro-2-pyridinol (TClP), were more cytotoxic for D3 mouse embryonic stem cells than for differentiated fibroblasts 3T3 cells. Exposure to 10 mu M CPF and TClP and 100 mu M CPO for 12 h significantly altered the in vitro expression of biomarkers of differentiation in D3 cells. Similarly, exposure to 20 mu M CPF and 25 mu M CPO and TClP for 3 days also altered the expression of the biomarkers in the same model. These exposures caused no significant reduction in D3 viability with mild inhibition of acetylcholinesterase and neuropathy target esterase by CPF and severe inhibition by CPO. We conclude that certain in vivo exposure scenarios are possible, which cause inhibition of acetylcholinesterase but without clinical symptoms that reach high enough systemic CPF concentrations able to alter the expression of genes involved in cellular differentiation with potentially hazard effects on development. Conversely, the risk for embryotoxicity by CPO and TClP was very low because the required exposure would induce severe cholinergic syndrome. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 35 条
  • [1] Dose-effect analyses of occupational chlorpyrifos exposure and peripheral nerve electrophysiology
    Albers, James W.
    Garabrant, David H.
    Mattsson, Joel L.
    Burns, Carol J.
    Cohen, Sarah S.
    Sima, Cami
    Garrison, Richard P.
    Richardson, Rudy J.
    Berent, Stanley
    [J]. TOXICOLOGICAL SCIENCES, 2007, 97 (01) : 196 - 204
  • [2] The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study
    Albers, JW
    Garabrant, DH
    Schweitzer, SJ
    Garrison, RP
    Richardson, RJ
    Berent, S
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2004, 61 (03) : 201 - 211
  • [3] Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism
    Atterberry, TT
    Burnett, WT
    Chambers, JE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 147 (02) : 411 - 418
  • [4] Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests
    Brown, NA
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2002, 30 (02): : 177 - 198
  • [5] Long-term neurotoxicity of chlorpyrifos:: Spatial learning impairment on repeated acquisition in a water maze
    Cañadas, F
    Cardona, D
    Dávila, E
    Sánchez-Santed, F
    [J]. TOXICOLOGICAL SCIENCES, 2005, 85 (02) : 944 - 951
  • [6] Different reaction patterns of dopamine content to prenatal exposure to chlorpyrifos in different periods
    Chen, Xiao-Ping
    Wang, Xiang
    Dong, Jing-Yin
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2011, 31 (04) : 355 - 359
  • [7] Determination of the reference dose for chlorpyrifos: Proceedings of an expert panel
    Clegg, DJ
    van Gemert, M
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 1999, 2 (03): : 211 - 255
  • [8] Appraisal of risks from nonoccupational exposure to chlorpyrifos
    Cochran, RC
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (01) : 105 - 121
  • [9] Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI [10.1080/10408440802272158, 10.1080/10408440802272158 ]
  • [10] A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY
    ELLMAN, GL
    COURTNEY, KD
    ANDRES, V
    FEATHERSTONE, RM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) : 88 - &